What is Coherus complete?
Coherus COMPLETE TM Co-Pay Assistance Program. Coherus COMPLETE TM offers a Co-Pay Assistance Program that covers out-of-pocket expenses related to UDENYCA® for commercially insured patients. Eligible patients qualify for $0 out-of-pocket costs for each UDENYCA® dose.* $15,000 maximum. annual benefit.
Is UDENYCA covered by insurance?
*As of July 1, 2019, United Healthcare is providing coverage for UDENYCA® for Medicare Advantage/Managed Medicare patients. For other UnitedHealthcare plans, a benefits verification check is recommended. **As of January 1, 2020, UDENYCA® will be covered by all Cigna health plans.
Is Udenyca the same as Neulasta?
Udenyca is a biosimilar of the reference product Neulasta. The US Food and Drug Administration (FDA) has approved Udencya as a biosimilar of Neulasta, which means it is "highly similar to, and has no clinically meaningful differences from" Neulasta - it is just as safe and effective and used in the same way.
Is there an alternative to Neulasta?
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white ...